Kolkata: Sanofi India announced that it has signed an agreement with India's largest wind turbine manufacturer, Suzlon EnergyBSE -2.20 % (SEL), for a 2.1 MW (megawatt) offsite windmill installation, to generate renewable power for captive consumption at its Ankleshwar manufacturing site.
Sanofi is one of few healthcare companies in the country exploring the use of renewable energy sources for its manufacturing operations. In 2012, Sanofi's Goa manufacturing site started using biomass from agro waste to generate energy. In addition to creating employment for local villagers, the biomass project helped reduce the site's steam cost as well as its dependence on fossil fuel.
"As a global healthcare leader, Sanofi believes that reducing our carbon footprint and using energy responsibly are part of our mission to help protect life on this planet. We strongly support the use of renewable energies, and hence initiated a study in 2012 to better understand the local renewable energy market in India to identify available opportunities", said Shailesh Ayyangar, managing director - India and vice-president South Asia in a statement.
The manufacturing site at Ankleshwar - one of Sanofi's three good manufacturing practices compliant state-of-the-art manufacturing sites in India - produces solid dose formulations and active pharma ingredient. Between its two facilities at Goa and Ankleshwar, Sanofi has the capacity to manufacture 8.5 billion tablets annually.
"We look forward to building a successful wind power project with Sanofi", said Tulsi Tanti, Chairman, Suzlon Group.
No comments:
Post a Comment